Two cohort studies used PD1 to treat melanoma, two cohort studies used CTLA4 to treat melanoma, one cohort study combined PD1 with CTLA4 to treat melanoma, and one cohort study used PD1 to treat gastric cancer. Here, PDCD1 is linked to melanoma.